3D printing is reaching new levels of excellence and value in the modern market with the CELLINK 'BIO X' 3D bioprinting device being the latest piece of equipment to be announced.
The printer enables tissue engineers to print using both syringe extrusion and pneumatic technologies for a variety of different uses in the medical field. The system works by utilizing a hydrogel material that offers a temporary support system for cells as they work to create their own matrix support. This means that living tissue, skin cells and much more can be printed using the printer as an effective component for oncology research.
The CELLINK 'BIO X' 3D bioprinting device identifies how technology is further expanding to further the implementation of bioprinting in the health and testing field.
What Makes This Trend Stand Out
- Bioprinting Advancements
- The CELLINK 'BIO X' 3D bioprinting device showcases advancements in 3D printing for the medical field.
- Hydrogel Support Systems
- The use of hydrogel material as a temporary support system in bioprinting opens up new opportunities for creating living tissue.
- Integration of Pneumatic Technologies
- The CELLINK 'BIO X' 3D bioprinting device demonstrates the integration of syringe extrusion and pneumatic technologies for versatile medical applications.
Sectors Adopting This
- Biotechnology
- Biotechnology companies can leverage bioprinting advancements to develop innovative solutions for regenerative medicine.
- Medical Devices
- Medical device manufacturers can explore the use of hydrogel support systems in their products to enhance tissue engineering capabilities.
- Pharmaceuticals
- Pharmaceutical companies can utilize the integration of pneumatic technologies in bioprinting devices for more efficient drug testing and personalized medicine applications.
